-
Mashup Score: 0Study: More stringent algorithms may better define CKD stage G4 - 2 month(s) ago
Chronic kidney disease stage G3 may be linked with considerable morbidity in a community-based setting, which shows a need for optimized early interventions, according to published data.โWe chose to investigate [CKD] because some of the patients experience rapid deterioration of their condition without us knowing exactly who,โ study author Christian Fynbo Christiansen, MD, PhD,
Source: www.healio.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 29A Jacksonville man received a card in the mail. It led him to give an extraordinary gift - 3 month(s) ago
Tara Mano mailed thousands of cards across the country looking for a kidney donor. A Jacksonville man who received one is donating his kidney this week to help her.
Source: www.firstcoastnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 14Health Canada approves use of Jardiance for patients with CKD - 3 month(s) ago
Health Canada has approved the use of Jardiance for the treatment of adults with chronic kidney disease, according to a press release.Jardiance (empagliflozin, Boehringer Ingelheim/Eli Lilly) is a once-daily oral treatment prescribed to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular and renal death in adults with CKD. More than 4 million people in Canada
Source: www.healio.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 28Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease - 5 month(s) ago
Nature Communications – African Americans have an elevated risk of developing chronic kidney disease, yet only a fraction of those with high-risk genotypes develop the disease. Here, the authors…
Source: www.nature.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Research Grants for Professionals | National Kidney Foundation โ Serving Maryland and Delaware - 6 month(s) ago
The National Kidney Foundation Serving Maryland & Delaware (NKFMDDE) is pleased to announce our Research Application Portal OPENS Monday, October 2, 2023 and closes on Monday, December 4, 2023 at 5:00pm. Over the years, the National Kidney Foundation has invested over $100 mil lion to support the treatment of kidney disease. Locally, the National Kidney Foundation Serving Maryland & Delaware (NKFMDDE) has been able to distribute over $3,500,000 over the last few decades for pilot projects and for those
Source: www.kidneymd.orgCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Slow walking pace and weight gain may be linked to chronic kidney disease risk in adults who have obesity but not diabetes, according to a study by Drexel University researchers. Results from the College of Medicine and Dornsife School of Public Health suggest staying fit and avoiding weight gain may be more pivotal than weight loss alone to reduce CKD risk.
Source: www.healio.comCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0Call for Submissions: In A Few Words - 7 month(s) ago
โA doctor, like a writer, must have a voice of his own, something that conveys the timbre, the rhythm, the diction, and the music of his humanity, that compensates us for all the speechless machineโฆ
Source: ajkdblog.orgCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0
A new value-based care agreement has been announced between Humana and Interwell Health, a kidney care management company, in 13 states. | Humana and Interwell Health, a kidney care management company, have partnered to begin a new value-based care agreement to certain Medicare Advantage members in 13 states.
Source: www.fiercehealthcare.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Dr. Scott Solomon: Dapagliflozin Benefits Patients With Heart Failure, Kidney Disease - 8 month(s) ago
Home > ESC Congress 2023 > Dr. Scott Solomon: Dapagliflozin Benefits Patients With Heart Failure, Kidney Disease A pooled analysis from the DELIVER and DAPA-HF trials assessed the efficacy of FARXIGA (dapagliflozin) in patients with heart failure and deteriorating kidney function. The findings, which demonstrated clinical benefit, were presented at the European Society of Cardiology Congress 2023. In this exclusive interview, DocWire News spoke with the presenting investigator, Dr. Scott Solomon, of
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 1Pig-Kidney Xenotransplants Prove Successful in Two Brain-Dead Men - 8 month(s) ago
‘Life-sustaining kidney function’ was seen with gene-edited pig kidneys
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
๐ Study: More stringent algorithms may better define chronic #kidneydisease stage G4. ๐ The 3-year risk of rapid progression among adults in the study cohort was 14.6%. https://t.co/7FIp31OVHK